Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Xinqiao Hospital of Chongqing
With
Primary Objectives 1. To determine the safety of CD22.CAR-T cells in lymphoma patients refractory or resistent to anti-CD19:TCRz:CD28 CAR-T cells 2. To determine in vivo dynamics and persistency of CD22.CAR-T cells. Secondary Objectives 1. To determine the feasibility of CD22.CAR-T cells in lymphoma patients refractory or resistent to anti-CD19:TCRz:CD28 CAR-T cells 2. To determine in vivo dynamics and persistency of CD22.CAR-T cells. 3. To assess the intratumoral infiltration of CD22.CAR-T cells. 4. To correlate the subsets and differentiation of CD22.CAR-T cells to observed anti-tumor efficacy
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
